DE60117096D1 - Dihydroindol- und tetrahydrochinolinderivate - Google Patents
Dihydroindol- und tetrahydrochinolinderivateInfo
- Publication number
- DE60117096D1 DE60117096D1 DE60117096T DE60117096T DE60117096D1 DE 60117096 D1 DE60117096 D1 DE 60117096D1 DE 60117096 T DE60117096 T DE 60117096T DE 60117096 T DE60117096 T DE 60117096T DE 60117096 D1 DE60117096 D1 DE 60117096D1
- Authority
- DE
- Germany
- Prior art keywords
- dihydroindol
- tetrahydrochinoline
- derivatives
- tetrahydrochinoline derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- Urology & Nephrology (AREA)
- Dermatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00128063 | 2000-12-21 | ||
EP00128063 | 2000-12-21 | ||
PCT/EP2001/014620 WO2002050041A1 (en) | 2000-12-21 | 2001-12-12 | Dihydroindole and tetrahydroquinoline derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60117096D1 true DE60117096D1 (de) | 2006-04-20 |
DE60117096T2 DE60117096T2 (de) | 2006-11-23 |
Family
ID=8170751
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60117096T Expired - Lifetime DE60117096T2 (de) | 2000-12-21 | 2001-12-12 | Dihydroindol- und tetrahydrochinolinderivate |
Country Status (15)
Country | Link |
---|---|
US (2) | US6706751B2 (de) |
EP (1) | EP1358162B1 (de) |
JP (1) | JP4068459B2 (de) |
KR (1) | KR100530408B1 (de) |
CN (1) | CN1208322C (de) |
AR (1) | AR035408A1 (de) |
AT (1) | ATE317386T1 (de) |
AU (2) | AU2002219176B2 (de) |
BR (1) | BR0116263A (de) |
CA (1) | CA2431100C (de) |
DE (1) | DE60117096T2 (de) |
ES (1) | ES2257381T3 (de) |
MX (1) | MXPA03005395A (de) |
WO (1) | WO2002050041A1 (de) |
ZA (1) | ZA200304646B (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PE20040522A1 (es) | 2002-05-29 | 2004-09-28 | Novartis Ag | Derivados de diarilurea dependientes de la cinasa de proteina |
NZ538031A (en) * | 2002-08-29 | 2007-10-26 | Merck & Co Inc | Indoles having anti-diabetic activity |
TW200510271A (en) * | 2003-08-08 | 2005-03-16 | Ube Industries | Alkynyl substituded condensed heterocyclic compound, method for producing the same and organic electroluminescence element using the same |
TWI329102B (en) * | 2006-08-15 | 2010-08-21 | Nat Health Research Institutes | Thiourea compounds and method for inhibiting hepatitis c virus infection |
WO2008124300A1 (en) * | 2007-04-10 | 2008-10-16 | National Health Research Institutes | Hepatitis c virus inhibitors |
US7897764B2 (en) * | 2007-06-08 | 2011-03-01 | National Health Research Institutes | Thiourea derivatives |
TWI361808B (en) * | 2008-01-08 | 2012-04-11 | Nat Health Research Institutes | Imidazolidinone and imidazolidinethione derivatives |
US8198284B2 (en) * | 2008-04-30 | 2012-06-12 | National Health Research Institutes | Treatment of neurodegenerative disorders with thiourea compounds |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3997542A (en) * | 1975-06-23 | 1976-12-14 | Sterling Drug Inc. | 1-(Halogenated-acetyl)-1,2,3,4-tetrahydro-6-quinolinols and esters thereof |
NZ227042A (en) | 1987-11-27 | 1991-05-28 | Banyu Pharma Co Ltd | Substituted alkylamine derivatives and pharmaceutical compositions |
US5288749A (en) | 1991-12-20 | 1994-02-22 | Abbott Laboratories | Tertiary and secondary amines as alpha-2 antagonists and serotonin uptake inhibitors |
TW438774B (en) | 1993-07-14 | 2001-06-07 | Hoffmann La Roche | Pharmaceutical composition for lowering cholesterol containing phenalkylamines and certain novel phenalkylamines |
US6313127B1 (en) | 1996-02-02 | 2001-11-06 | Zeneca Limited | Heterocyclic compounds useful as pharmaceutical agents |
DE19727117A1 (de) | 1997-06-26 | 1999-01-07 | Boehringer Ingelheim Pharma | Phenylalkylderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
CA2408913A1 (en) | 2000-05-16 | 2001-11-22 | Takeda Chemical Industries, Ltd. | Melanin-concentrating hormone antagonist |
-
2001
- 2001-12-11 US US10/014,959 patent/US6706751B2/en not_active Expired - Fee Related
- 2001-12-12 JP JP2002551538A patent/JP4068459B2/ja not_active Expired - Fee Related
- 2001-12-12 ES ES01271362T patent/ES2257381T3/es not_active Expired - Lifetime
- 2001-12-12 AU AU2002219176A patent/AU2002219176B2/en not_active Ceased
- 2001-12-12 AU AU1917602A patent/AU1917602A/xx active Pending
- 2001-12-12 EP EP01271362A patent/EP1358162B1/de not_active Expired - Lifetime
- 2001-12-12 DE DE60117096T patent/DE60117096T2/de not_active Expired - Lifetime
- 2001-12-12 WO PCT/EP2001/014620 patent/WO2002050041A1/en active IP Right Grant
- 2001-12-12 BR BR0116263-2A patent/BR0116263A/pt not_active IP Right Cessation
- 2001-12-12 AT AT01271362T patent/ATE317386T1/de not_active IP Right Cessation
- 2001-12-12 KR KR10-2003-7008393A patent/KR100530408B1/ko not_active IP Right Cessation
- 2001-12-12 CN CNB018210120A patent/CN1208322C/zh not_active Expired - Fee Related
- 2001-12-12 MX MXPA03005395A patent/MXPA03005395A/es active IP Right Grant
- 2001-12-12 CA CA002431100A patent/CA2431100C/en not_active Expired - Fee Related
- 2001-12-20 AR ARP010105925A patent/AR035408A1/es unknown
-
2003
- 2003-06-13 ZA ZA200304646A patent/ZA200304646B/en unknown
- 2003-08-26 US US10/648,451 patent/US7102007B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2431100A1 (en) | 2002-06-27 |
US20050020624A1 (en) | 2005-01-27 |
US20030004156A1 (en) | 2003-01-02 |
KR100530408B1 (ko) | 2005-11-22 |
JP2004519441A (ja) | 2004-07-02 |
EP1358162A1 (de) | 2003-11-05 |
US6706751B2 (en) | 2004-03-16 |
ZA200304646B (en) | 2004-09-13 |
AR035408A1 (es) | 2004-05-26 |
AU2002219176B2 (en) | 2006-02-09 |
CA2431100C (en) | 2009-03-24 |
JP4068459B2 (ja) | 2008-03-26 |
CN1208322C (zh) | 2005-06-29 |
DE60117096T2 (de) | 2006-11-23 |
EP1358162B1 (de) | 2006-02-08 |
MXPA03005395A (es) | 2003-09-25 |
CN1481366A (zh) | 2004-03-10 |
ES2257381T3 (es) | 2006-08-01 |
ATE317386T1 (de) | 2006-02-15 |
BR0116263A (pt) | 2003-12-30 |
WO2002050041A1 (en) | 2002-06-27 |
AU1917602A (en) | 2002-07-01 |
KR20030063453A (ko) | 2003-07-28 |
US7102007B2 (en) | 2006-09-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1292604T3 (da) | 2-Aminocarbonyl-9H-purinderivater | |
DE50112013D1 (de) | Deodorantien und antiperspirantien | |
IS6385A (is) | Ný notkun og nýjar N-asabísýkló-amíð afleiður | |
AR028343A1 (es) | Derivados de pirrolidina y piperidina | |
ATE540013T1 (de) | Naphthalinderivate | |
EE200300071A (et) | Kinasoliini derivaadid | |
ATE288437T1 (de) | Tetrahydro-heterocycloazepinyl-pyrimidin-deriva e | |
ATE298332T1 (de) | Decahydro-isochinolinderivate | |
DK1280809T3 (da) | Antitumorecteinascidinderivater | |
NO20025510L (no) | Dibenzoazulen-derivater samt anvendelse derav | |
DK1571140T3 (da) | Substituerede C-cyjklohexylmethylamin-derivater | |
AR028602A1 (es) | Derivados de pirrol | |
AR028282A1 (es) | Derivados de aminofenil pirimidona | |
DE60032898D1 (de) | Arylthiazolidindion- und aryloxazolidinderivate | |
DK1322593T3 (da) | O-substituerede-6-methyl-tramadol-derivater | |
ATE282021T1 (de) | Substituierte aminomethyl-phenyl- cyclohexanderivate | |
DE50113112D1 (de) | Schaltungsanordnung | |
DE60117096D1 (de) | Dihydroindol- und tetrahydrochinolinderivate | |
ATE280752T1 (de) | Aminomethyl-phenyl-cyclohexanonderivate | |
NO20024617L (no) | Aryl- og heteroarylsulfonater | |
ATE299873T1 (de) | Substituierte c-furan-2-yl-methylamin- und c- thiophen-2-yl-methylamin-derivate | |
DE50112454D1 (de) | Substituierte 5-amino-1-penten-3-ol-derivate | |
DE60118970D1 (de) | Indol- und dihydroindolderivate | |
ATE374776T1 (de) | Pyrrolotriazolopyrimidinonderivate | |
NO20024393D0 (no) | 2-fenylpyran-4-on-derivater |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |